NCT00944437

Brief Summary

The aim of this study is to compare two methods of delivery of noninvasive mechanical ventilation (NIV). Since patient compliance and mechanical characteristics of the delivery devices are two fundamental variables in the success of NIV during acute respiratory failure, our hypothesis is that an improved patient-ventilator interface may improve the efficacy of therapy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 23, 2009

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

November 5, 2013

Status Verified

November 1, 2013

Enrollment Period

2.2 years

First QC Date

July 21, 2009

Last Update Submit

November 4, 2013

Conditions

Keywords

Ventilation, MechanicalPositive-Pressure RespirationContinuous Positive Airway Pressure

Outcome Measures

Primary Outcomes (1)

  • Differences in PaO2/FiO2 ratio with respect to baseline (before NIV) values.

    24 h

Secondary Outcomes (9)

  • PaO2/FiO2 improvement at 1 h after beginning of ventilation.

    1 h after enrollment

  • Arterial carbon dioxide partial pressure (PaCO2)

    At 1 and 24 h post-enrollment

  • Arterial blood pressure and incidence of hypotension (systolic blood pressure <90 mmHg or mean arterial blood pressure <60 mmHg)

    Up to 24 h post-enrollment

  • Need for intubation

    Up to 24 h post-enrollment

  • Intensive care unit stay

    Up to 30 days

  • +4 more secondary outcomes

Study Arms (2)

Helmet

ACTIVE COMPARATOR

Patients in this group will receive continuous positive airway pressure delivered through a helmet connected to a high-flow reservoir system.

Device: Helmet

Mask

EXPERIMENTAL

Patients in this group will receive continuous positive-airway pressure delivered through a novel full-face mask connected to a high-flow system. Expiratory pressure will be maintained using an expiratory valve connected to a T-tube.

Device: Full-face mask

Interventions

HelmetDEVICE

Continuous positive airway pressure for up to 24 h. Initial pressure will be 5 cmH2O, and will be increased by 2-3 cmH2O up to 10 cmH2O, in order to maintain SpO2 ≥90%.

Also known as: Continuous Positive Airway Pressure, Noninvasive Ventilation, 4-Vent helmet (Rüsch, Germany)
Helmet

Continuous positive airway pressure for up to 24 h. Initial pressure will be 5 cmH2O, and will be increased by 2-3 cmH2O up to 10 cmH2O, in order to maintain SpO2 ≥90%.

Also known as: Continuous Positive Airway Pressure, Noninvasive Ventilation, Novastar mask (Dräger GmbH, Lubeck, Germany)
Mask

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ongoing or recent history of respiratory failure (either primary or secondary)
  • PaO2 \<60 mmHg if breathing room air or PaO2/FiO2 \<300 mmHg if receiving supplemental oxygen
  • Acute dyspnea with respiratory rate \>25 bpm and accessory muscle recruitment and/or paradoxical abdominal breathing

You may not qualify if:

  • Refusing noninvasive ventilation
  • Comatose (Glasgow Coma Scale \<8) or unable to maintain a patent airway
  • Hemodynamically unstable (systolic blood pressure \<80 mmHg on recruitment, or receiving vasopressors/inotropes; ongoing angina/myocardial infarction; newly-developed arrhythmia with hemodynamic impact)
  • Having recently (≤2 weeks) undergone oesophageal or upper respiratory tract surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University and Hospital of Parma (Azienda Ospedaliero-Universitaria di Parma)

Parma, PR, 43126, Italy

Location

Related Publications (9)

  • Appendini L, Patessio A, Zanaboni S, Carone M, Gukov B, Donner CF, Rossi A. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994 May;149(5):1069-76. doi: 10.1164/ajrccm.149.5.8173743.

    PMID: 8173743BACKGROUND
  • Celikel T, Sungur M, Ceyhan B, Karakurt S. Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure. Chest. 1998 Dec;114(6):1636-42. doi: 10.1378/chest.114.6.1636.

    PMID: 9872200BACKGROUND
  • Chadda K, Clair B, Orlikowski D, Macadoux G, Raphael JC, Lofaso F. Pressure support versus assisted controlled noninvasive ventilation in neuromuscular disease. Neurocrit Care. 2004;1(4):429-34. doi: 10.1385/NCC:1:4:429.

    PMID: 16174945BACKGROUND
  • Collaborative Research Group of Noninvasive Mechanical Ventilation for Chronic Obstructive Pulmonary Disease. Early use of non-invasive positive pressure ventilation for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial. Chin Med J (Engl). 2005 Dec 20;118(24):2034-40.

    PMID: 16438899BACKGROUND
  • Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med. 2004 Dec;32(12):2516-23. doi: 10.1097/01.ccm.0000148011.51681.e2.

    PMID: 15599160BACKGROUND
  • Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med. 1995 Jun;151(6):1799-806. doi: 10.1164/ajrccm.151.6.7767523.

    PMID: 7767523BACKGROUND
  • Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA. 2005 Dec 28;294(24):3124-30. doi: 10.1001/jama.294.24.3124.

    PMID: 16380593BACKGROUND
  • Meduri GU, Turner RE, Abou-Shala N, Wunderink R, Tolley E. Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest. 1996 Jan;109(1):179-93. doi: 10.1378/chest.109.1.179.

    PMID: 8549183BACKGROUND
  • Meduri GU, Fox RC, Abou-Shala N, Leeper KV, Wunderink RG. Noninvasive mechanical ventilation via face mask in patients with acute respiratory failure who refused endotracheal intubation. Crit Care Med. 1994 Oct;22(10):1584-90.

    PMID: 7924369BACKGROUND

MeSH Terms

Conditions

Respiratory InsufficiencyRespiratory Distress SyndromePulmonary Disease, Chronic ObstructivePulmonary EdemaRespiratory Aspiration

Interventions

Head Protective DevicesContinuous Positive Airway PressureNoninvasive Ventilation

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesLung DiseasesLung Diseases, ObstructiveChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Personal Protective EquipmentProtective DevicesEquipment and SuppliesManufactured MaterialsTechnology, Industry, and AgriculturePositive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Guido Fanelli, MD

    Dept. of Anesthesiology and Critical Care Medicine, University of Parma, Italy

    STUDY CHAIR
  • Maria Barbagallo, MD

    UO II Anestesia, Rianimazione e Terapia Antalgica, Azienda Ospedaliero-Universitaria di Parma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology and Director, Anesthesia, Critical Care and Pain Medicine

Study Record Dates

First Submitted

July 21, 2009

First Posted

July 23, 2009

Study Start

May 1, 2008

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

November 5, 2013

Record last verified: 2013-11

Locations